Opendata, web and dolomites

MOBIUS SIGNED

MØBIUS: Transforming medication management for improved patient safety

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MOBIUS project word cloud

Explore the words cloud of the MOBIUS project. It provides you a very rough idea of what is the project "MOBIUS" about.

wasting    brings    improves       time    countries    eliminating    winning    health    drug    2021    medication    commercial    proposition    bius    sme    unused    entire    improvement    integration    prescription    traceability    dispensation    facilities    20    electronic    jobs    solution    cumulative    95    intends    linking    dispensing    13    thula    accountability    class    healthcare    plan    transform    integrating    commercialization    hospital    expenditures    software    exchange    patient    medicines    robots    loops    22    reduces    oslash    inst    validating    pharmacies    fraction    integrates    stock    seal    designed    award    excellence    flow    pharmaceuticals    sufficient    finalizing    manual    oecd    inefficiencies    dramatically    errors    medicine    services    investment    enhanced    automation    logistics    implementable    saves    submission    data    packaging    market    ensures    waste    roi    prescriptions    first    automated    generate    company    q1    security    business    search    platform    entry    companies    mission    removes    safety    strategy    drugs    iceland    solutions    realistic   

Project "MOBIUS" data sheet

The following table provides information about the project.

Coordinator
THULA-NORRAENT HUGVIT EHF 

Organization address
address: GLERARGOTU 28
city: AKUREYRI
postcode: 600
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Iceland [IS]
 Project website http://thula.is
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THULA-NORRAENT HUGVIT EHF IS (AKUREYRI) coordinator 50˙000.00

Map

 Project objective

Thula is an award-winning IT company based in Iceland with the mission of providing first class e-health solutions for medication management, logistics and electronic exchange of healthcare information. Thula has developed MØBIUS, a unique software solution that can manage the entire medication flow of hospital pharmacies, long-term healthcare facilities or companies providing healthcare services and logistics. Pharmaceuticals account for 20% of overall healthcare expenditures in OECD countries but a significant fraction of this investment could be reduced by eliminating inefficiencies in drug management (e.g., errors in prescription and dispensation; waste of unused medicines). MØBIUS is an integration platform designed to transform medicine management through enhanced automation. By linking different systems in the medication- and logistics loops, MØBIUS dramatically reduces inefficiencies in stock management and increases patient safety and security. MØBIUS integrates Electronic Prescriptions, automated dispensing robots and distribution systems. It also ensures availability of sufficient drugs for the patient, processes drug dispensing effectively, removes time wasting, saves resources, allows easy access to medicine, brings on more security on the data compared to manual-based systems, and improves accountability and traceability. The objectives of the SME Inst project include finalizing and validating the development of MØBIUS by integrating and packaging advanced features; search of commercial partners in target EU countries; in-depth assessment of entry strategy into the EU healthcare market; and a realistic and implementable business plan. We expect MØBIUS will generate about 40 new jobs and a cumulative ROI of €5.95 in the first 4 years after commercialization in Q1 2021. This submission, an improvement of a previous call in which we achieved a Seal of Excellence (13.22), intends to further demonstrate MØBIUS’ approach and our company’s value proposition.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOBIUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOBIUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Read More  

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More